Possible impact of and supplementation on sars-cov-2 infection risk and covid-19 symptoms in cohort of patients with inflammatory bowel disease

HIGHLIGHTS

  • who: Amedeo De Nicolu00f2 and collaborators from the Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Turin, Italy have published the article: Possible Impact of and Supplementation on SARS-CoV-2 Infection Risk and COVID-19 Symptoms in Cohort of Patients with Inflammatory Bowel Disease, in the Journal: Nutrients 2023, 15, 169. of 20/Dec/2022
  • what: The aim of the study was to evaluate the relationship between serum VD levels and supplementation, and SARS-CoV2 infection, COVID-19 symptoms, IgG positivity, and titers in a cohort of patients with . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?